CMPR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CMPR is a good buy right now for a beginner with a long-term horizon and $50,000-$100,000 to invest. The stock shows a constructive technical setup, supportive analyst sentiment, favorable options positioning, and clear operational catalysts from debt refinancing and improved EBITDA outlook. Given the investor wants a direct answer and is not waiting for a perfect entry, the current price area around 96 is acceptable for initiating a long-term position.
CMPR’s trend is moderately bullish. The stock is trading above key moving averages with SMA_5 > SMA_20 > SMA_200, which supports an uptrend. MACD histogram is positive at 0.225, though it is contracting, suggesting momentum is still positive but not accelerating. RSI_6 at 52.0 is neutral, so the stock is not overbought. Price is close to pivot support at 95.843, with nearby resistance at 102.203 and then 106.132. The setup suggests the trend is intact and the current level is a reasonable entry for a long-term buyer.
["Cimpress announced a $1.1 billion 7-year Term Loan B to optimize capital structure and lower financing costs.", "The company is extending its $250 million revolving credit facility to 2031, improving liquidity.", "Management projects at least $465 million in FY 2026 adjusted EBITDA and more than 10% growth in FY 2027 adjusted EBITDA.", "Analysts recently raised price targets to $110 and $113 while maintaining Buy/Outperform ratings.", "Hedge funds are buying, with buying amount up 155.46% over the last quarter.", "Post-market change was positive at 0.88%, suggesting some resilience after the regular session."]
["The stock closed down 2.58% in the regular session, showing some short-term selling pressure.", "MACD momentum is positive but contracting, so upside may be less immediate than earlier in the move.", "Similar candlestick pattern analysis suggests a 60% chance of a -4.22% move next day and -2.65% next week.", "Insiders are neutral with no significant trading trends over the last month.", "No recent congress trading data is available."]
Latest quarter details were not fully provided due to a financial snapshot error, but the available commentary indicates strong recent execution. Truist noted Q3 was the third beat in as many quarters, reflecting sustained demand for higher-value offerings, good execution, and benefits from cross-Cimpress fulfillment. Management also guided to at least $465 million FY 2026 adjusted EBITDA and over 10% growth in FY 2027 adjusted EBITDA, which points to improving growth trends.
Analyst sentiment is clearly positive. Barrington raised its price target to $113 from $95 and kept an Outperform rating, citing positive estimate revisions and a modestly higher valuation assumption. Truist raised its target to $110 from $100 and kept a Buy rating, highlighting three straight quarterly beats and solid demand. The Wall Street view is bullish overall, with pros emphasizing earnings momentum, improved execution, refinancing benefits, and upside to targets. The main con is that the stock has already run up significantly year-to-date, so near-term upside may be more measured.
